Evidence map›Paper›PMID 25110636›Full record

ArticleThe lancet. Psychiatry2014

Violent crime, suicide, and premature mortality in patients with schizophrenia and related disorders: a 38-year total population study in Sweden.

Seena Fazel, Achim Wolf, Camilla Palm, Paul Lichtenstein

Open access · hybridAbstract read
In one paragraph

Article in The lancet. Psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed, 5 pooled it
18.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 5 syntheses or guidelines pooled it, 299 citations in OpenAlex.

  1. Pooled it
  2. Systematic review of risk factors for violence in psychosis: 10-year update.The British journal of psychiatry : the journal of mental science · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Seena FazelDepartment of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK (S Fazel MD, A Wolf MSc); and Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (C Palm MSc, Prof P Lichtenstein PhD).
Achim WolfDepartment of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK (S Fazel MD, A Wolf MSc); and Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (C Palm MSc, Prof P Lichtenstein PhD).
Camilla PalmDepartment of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK (S Fazel MD, A Wolf MSc); and Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (C Palm MSc, Prof P Lichtenstein PhD).
Paul LichtensteinDepartment of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK (S Fazel MD, A Wolf MSc); and Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (C Palm MSc, Prof P Lichtenstein PhD).
Warneford Hospital · GB

Funding

Wellcome Trust 095806
6 · The paper itself

Abstract

backgroundPeople with schizophrenia and related disorders are at an increased risk of adverse outcomes, including conviction of a violent offence, suicide, and premature mortality. However, the rates of, and risk factors for, these outcomes need clarification as a basis for population-based and targeted interventions. We aimed to determine rates and risk factors for these outcomes, and investigate to what extent they are shared across outcomes and are specific to schizophrenia and related disorders.

methodsWe undertook a total population cohort study in Sweden of 24 297 patients with schizophrenia and related disorders between January, 1972 and December, 2009. Patients were matched by age and sex to people from the general population (n=485 940) and also to unaffected sibling controls (n=26 357). First, we investigated rates of conviction of a violent offence, suicide, and premature mortality, with follow-up until conviction of a violent offence, emigration, death, or end of follow-up (Dec 31, 2009), whichever occurred first. Second, we analysed associations between these adverse outcomes and sociodemographic, individual, familial, and distal risk factors, for men and women separately, with Cox proportional hazards models. Finally, we assessed time trends in adverse outcomes between 1972 and 2009, for which we compared patients with unaffected siblings, and analysed associations with changes in the number of nights spent in inpatient beds in psychiatric facilities nationwide.

findingsWithin 5 years of their initial diagnosis, 13·9% of men and 4·7% of women with schizophrenia and related disorders had a major adverse outcome (10·7% of men and 2·7% of women were convicted of a violent offence, and 3·3% of men and 2·0% of women died prematurely of any cause). During the study, the adjusted odds ratio of any adverse outcomes for patients compared with general population controls was 7·5 (95% CI 7·2-7·9) in men and 11·1 (10·2-12·1) in women. Three risk factors that were present before diagnosis were predictive of any adverse outcome: drug use disorders, criminality, and self-harm, which were also risk factors for these outcomes in unaffected siblings and in the general population. Over the period 1973-2009, the odds of these outcomes increased in patients with schizophrenia and related disorders compared with unaffected siblings.

interpretationSchizophrenia and related disorders are associated with substantially increased rates of violent crime, suicide, and premature mortality. Risk factors for these three outcomes included both those specific to individuals with schizophrenia and related disorders, and those shared with the general population. Therefore, a combination of population-based and targeted strategies might be necessary to reduce the substantial rates of adverse outcomes in patients with schizophrenia and related disorders.

Identifiers

PMID25110636
PMCPMC4124855
OpenAlexW2165822531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.